Literature DB >> 21337286

[The usefulness of the Brief Symptom Inventory 18 (BSI-18) in psychotherapeutic patients].

Gabriele Helga Franke1, Annegret Ankerhold, Matthais Haase, Susanne Jäger, Christfried Tögel, Cornelia Ulrich, Jörg Frommer.   

Abstract

The BSI-18, an abridged version of the Brief Symptom Inventory of Derogatis, contains the 3 six items scales Somatization, Depression, Anxiety, and the Global Score (GSI). In a sample of N=638 psychotherapeutic patients, reliability and validity were proven. Reliability of the 3 scales was good: Somatization α=0.79, Depression α=0.84, Anxiety α=0.84, and GSI α=0.91. The postulated three-factor structure was proven sufficiently using confirmatory and explorative factor analyses. The questionnaire separated different patients groups. Judgments of the therapists corresponded well with the self-rating behavior of the patients. In conclusion, the psychometric evaluation of the BSI-18 resulted in persuasive evidence for its reliability and validity. The loss of information, as a result of item reduction, is acceptable analyzing large samples; in cases of individual analyses, the SCL-90-R is advised. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21337286     DOI: 10.1055/s-0030-1270518

Source DB:  PubMed          Journal:  Psychother Psychosom Med Psychol        ISSN: 0937-2032


  32 in total

1.  Do Self-efficacy Expectation and Spirituality Provide a Buffer Against Stress-Associated Impairment of Health? A Comprehensive Analysis of the German Pastoral Ministry Study.

Authors:  Eckhard Frick; Arndt Büssing; Klaus Baumann; Wolfgang Weig; Christoph Jacobs
Journal:  J Relig Health       Date:  2016-04

2.  Reactions and Strategies of German Catholic Priests to Cope with Phases of Spiritual Dryness.

Authors:  Arndt Büssing; Jochen Sautermeister; Eckhard Frick; Klaus Baumann
Journal:  J Relig Health       Date:  2017-06

3.  [Listening to music in old age : Investigation of utilization and psychosocial resources].

Authors:  Thomas Schäfer; Jasmin Riedel
Journal:  Z Gerontol Geriatr       Date:  2017-04-18       Impact factor: 1.281

4.  Quality of life among parents seeking treatment for their child's functional abdominal pain.

Authors:  Claudia Calvano; Petra Warschburger
Journal:  Qual Life Res       Date:  2018-06-14       Impact factor: 4.147

5.  Commitment to Celibacy in German Catholic Priests: Its Relation to Religious Practices, Psychosomatic Health and Psychosocial Resources.

Authors:  Klaus Baumann; Christoph Jacobs; Eckhard Frick Sj; Arndt Büssing
Journal:  J Relig Health       Date:  2017-04

6.  Is adjustment disorder unidimensional or multidimensional? Implications for ICD-11.

Authors:  Louisa Lorenz; Philip Hyland; Axel Perkonigg; Andreas Maercker
Journal:  Int J Methods Psychiatr Res       Date:  2017-10-08       Impact factor: 4.035

7.  Factorial structure of the Brief Symptom Inventory (BSI)-18 among Chinese drug users.

Authors:  Jichuan Wang; Brian C Kelly; Tieqiao Liu; Guanbai Zhang; Wei Hao
Journal:  Drug Alcohol Depend       Date:  2013-07-29       Impact factor: 4.492

8.  [Religious/spiritual well-being in mentally ill persons III: first results of a body-centered awareness meditation for in-patient rehabilitation].

Authors:  Human-Friedrich Unterrainer; Andreas J Eisner; Ewald Pollheimer; Andrea Ackermann; Paul Kaufmann; Andreas Fink; Hans-Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2014-06-05

9.  [German version of the Skin Shame Scale (SSS-24) : Validation with dermatological patients and dermatologically healthy individuals].

Authors:  Michaela Hiebler-Ragger; Human-Friedrich Unterrainer; Andrew R Thompson; Stephen Kellett; Elisabeth Aberer
Journal:  Hautarzt       Date:  2020-02       Impact factor: 0.751

10.  Multidimensional Assessment of Interoceptive Abilities, Emotion Processing and the Role of Early Life Stress in Inflammatory Bowel Diseases.

Authors:  Konstantina Atanasova; Tobias Lotter; Wolfgang Reindl; Stefanie Lis
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.